Biotech 2050 Podcast

Science & Technology News

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

Episodes

Robert Plenge, EVP & Chief Research Officer, BMS: Reinventing Drug Discovery

Nello Mainolfi, Founder, President & CEO, Kymera: Pioneering Targeted Protein Degradation

Nick Myerberg, Partner & Head of AI at Braidwell on AI's Next Era in Drug Discovery

Robert Jacks, CEO of Sparrow Pharmaceuticals | Precision Medicine, Biotech Strategy & Leadership

Ardelyx Leaders Mike Raab & Laura Williams on Building Biotech Around Patients

Acadia CEO Catherine Owen Adams on Neurodegeneration, AI & Building Biotech Vision

Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership

Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics

Sheila Gujrathi, MD on Leadership, Biotech Innovation & The Mirror Effect for Women Leaders

Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms

Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation

Brian Hilberdink on Boehringer’s U.S. Growth, AI & Pharma’s Next Frontier

Johan Luthman, Lundbeck EVP R&D, on Rebuilding Neuroscience Pipelines & Drug Discovery

Christophe Bourdon, LEO Pharma CEO, on Dermatology Innovation, Rare Disease & Scalable Growth

Matt Gline, Roivant Sciences CEO, on Clinical Breakthroughs, Capital Discipline & Building Biotech

Jay Hartenbach, President & COO, Diakonos Oncology on Reprogramming Cancer Immunity Breakthrough AI

John Lepore, CEO & President - ProFound Therapeutics, on Proteome, AI, & Bold First-in-Class Drugs

Jason Kelly - Ginkgo Bioworks CEO and Co-Founder on Automation, AI Data & Biotech’s Reset

Arun Swaminathan: Coya CEO on Neuroinflammation, BD Strategy & Patient-Driven Biotech

How Nimbus CEO Abbas Kazimi Builds Resilient Pipelines Through Culture, Rigor & Smart Bets